Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan.

Raspagliesi, F; Kusamura, S; Campos Torres, J C; de Souza, G A; Ditto, A; Zanaboni, F; Younan, R; Baratti, D; Mariani, L; Laterza, B; Deraco, M

Raspagliesi, F; Kusamura, S; Campos Torres, J C; de Souza, G A; Ditto, A; Zanaboni, F; Younan, R; Baratti, D; Mariani, L; Laterza, B; Deraco, M.

Affiliation

Raspagliesi F; Department of Surgery-Gynaecology Unit, National Cancer Institute of Milan, Milan, Italy.

Eur J Surg Oncol ; 32(6): 671-5, 2006 Aug.

Article in En | MEDLINE | ID: mdl-16621425

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Hyperthermia, Induced; Ovarian Neoplasms/drug therapy; Ovarian Neoplasms/surgery; Adult; Aged; Cisplatin/administration & dosage; Combined Modality Therapy; Doxorubicin/administration & dosage; Female; Humans; Infusions, Parenteral; Middle Aged; Mitomycin/administration & dosage; Neoplasm Staging; Ovarian Neoplasms/pathology; Survival Rate; Treatment Outcome

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Hyperthermia, Induced Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 2006 Type: Article

Search on Google

XML

PubMed Links